Survival and extrapulmonary course of connective tissue disease after lung transplantation

Journal of Clinical Rheumatology

Volumn 18, Issue 6, 2012, Pages 283-289

  Takagishi, Troy ^a   Ostrowski, Rochella ^a   Alex, Charles ^b   Rychlik, Karen ^c   Pelletiere, Karen ^a   Tehrani, Rodney ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Departments of Pulmonary/Lung Transplant   (United States)

^c NONE

Author keywords

Connective tissue disease; Extrapulmonary; Lung transplantation; Recurrence; Survival

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONNECTIVE TISSUE DISEASE; DISEASE COURSE; FEMALE; FIBROSING ALVEOLITIS; HUMAN; LUNG GRAFT REJECTION; LUNG INSUFFICIENCY; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RECURRENT DISEASE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; CONNECTIVE TISSUE DISEASES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INCIDENCE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENCE; REGISTRIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84868239338     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3182676089     Document Type: Article

References (35)

1. Hant FN, Herpel LB, Silver RM. Pulmonary manifestations of scleroderma and mixed connective tissue disease. Clin Chest Med. 2010;31:433-449.
2. Antin-Ozerkis D, Evans J, Rubinowitz A, et al. Pulmonary manifestations of rheumatoid arthritis. Clin Chest Med. 2010;31:451-478.
3. Kamen DL, Strange C. Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med. 2010;31:479-488.
4. Kokosi M, Riemer EC, Highland KB. Pulmonary manifestations in Sjogren syndrome. Clin Chest Med. 2010;31:489-500.
5. Kalluri M, Oddis C. Pulmonary manifestations of the idiopathic inflammatory myopathies. Clin Chest Med. 2010;31:501-512.
6. Castelina FV, Varga J. Interstitial lung disease in connective tissue diseases: Evolving concepts of pathogenesis and management. Arthritis Res Ther. 2010;12:213.
7. Vonk M. Pulmonary arterial hypertension in connective tissue diseasesVa devastating complication. Eur Musculoskeletal Rev. 2007;2:44-47.
8. Kocheril SV, Appleton BE, Somers EC, et al. Comparison of disease progression and mortality of connective tissue diseaseYrelated interstitial lung disease and idiopathic interstitial pneumonia. Arthritis Rheum. 2005;53:549-557. (Pubitemid 41282803)
9. Lauretis A, Veeraraghavan S, Renzoni E. Connective tissue disease-Associated interstitial lung disease: How does it differ from IPF? How should the clinical approach differ? Chronic Respir Dis. 2011;8:53-82.
10. Park JH, Kim DS, Park JJ, et al. Prognosis of fibrotic interstitial pneumonia; idiopathic versus collagen vascular diseaseYrelated subtypes. Am J Respir Crit Care Med. 2007;175:705-711.
11. King TE. Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med. 2005;172:268-279.
12. Ryu JH, Bongartz T, Matteson EL. Interstitial lung disease in connective tissue diseases: what are the important questions? Arthritis Rheum. 2005;53:488-490. (Pubitemid 41278911)
13. Badesch DB, McGoon MD, Barst RJ, et al. Long-term survival among patients with scleroderma-Associated pulmonary arterial hypertension treated with intravenous epoprostenol. J Rheum. 2009;36:2244-2249.
14. Clements PJ, Tan M, McLaughlin VV, et al. The pulmonary arterial hypertension quality enhancement research initiative: Comparison of patients with idiopathic PAH to patients with systemic sclerosisYassociated PAH. Ann Rheum Dis. 2012;71:249-252.
15. Condliffe R, Kiely DG, Peacock AJ, et al. Connective tissue disease-Associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med. 2009;179:151-157.
16. Mathai SC, Hummers LK, Champion HC, et al. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases. Arthritis Rheum. 2009;60:569-577.
17. Kawut SM, Taichman DB, Archer-Chicko CL, et al. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest. 2003;123:344-350. (Pubitemid 36269414)
18. Christie JD, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation: Twenty-seventh official adult lung and heart-lung transplantation reportV2010. J Heart Lung Transplant. 2010;10:1089-1103.
19. Maurer JR, Frost AE, Estenne M, et al. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. J Heart Lung Transplant. 1998;17:703-709.
20. Orens JB, Estenne M, Arcasoy S, et al. International guideline for the selection of lung transplant candidates: 2006 updateVa consensus report from the pulmonary scientific council of the international society for heart and lung transplantation. J Heart Lung Transplant. 2006;25:745-755.
21. Yusen RD, Shearon TH, Qian Y, et al. Lung transplantation in the United States, 1999-2008. Am J Transplant. 2010;10:1047-1068.
22. McCue JD, Mooney J, Quail J, et al. Ninety-day mortality and major complications are not affected by use of lung allocation score. J Heart Lung Transplant. 2008;27:192-196. (Pubitemid 351221044)
23. Merlo CA, Weiss ES, Orens JB, et al. Impact of U.S. lung allocation score on survival after lung transplantation. J Heart Lung Transplant. 2009;28:769-775.
24. Lee CJ, Ahya VN. Lung transplantation in autoimmune diseases. Clin Chest Med. 2010;31:589-603.
25. Kubo M, Vensak J, Dauber J, et al. Lung transplantation in patients with scleroderma. J Heart Lung Transplant. 2001;20:174-175.
26. Levine SM, Anzueto A, Peters JI, et al. Single lung transplantation in patients with systemic disease. Chest. 1994;105:837-841. (Pubitemid 24088466)
27. Pigula FA, Griffith BP, Zenati MA, et al. Lung transplantation for respiratory failure resulting from systemic disease. Ann Thorac Surg. 1997;64:1630-1634. (Pubitemid 28066530)
28. Rosas V, Conte JV, Yang SC, et al. Lung transplantation and systemic sclerosis. Ann Transplant. 2000;5:38-43.
29. Saggar R, Khanna D, Furst DE, et al. Systemic sclerosis and bilateral lung transplantation: A single center experience. Eur Respir J. 2010;36:893-900.
30. Schachna L, Medsger TA, Dauber JH, et al. Lung transplantations in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension. Arthritis Rheum. 2006;54:3954-3961. (Pubitemid 44955899)
31. Shitrit D, Amital A, Peled N, et al. Lung transplantation in patients with scleroderma: Case series; review of the literature, and criteria for transplantation. Clin Transplant. 2009;23:178-183.
32. Massad MG, Powell CR, Kpodonu J, et al. Outcomes of lung transplantation in patients with scleroderma. World J Surg. 2005;29:1510-1515. (Pubitemid 41712692)
33. Showkat A, Lo A, Shokouh-Amiri H, et al. Are autoimmune diseases or glomerulonephritis affecting the development of panel-reactive antibodies in candidates for renal transplant? Transplant Proc. 2005;37:645-647.
34. Thervet E, Anglicheau D, Legendre C. Recent issues concerning renal transplantation in systemic lupus erythematosus patients. Nephrol Dial Transplant. 2001;16:12-14. (Pubitemid 32051466)
35. Padilla ML, Schilero GJ, Teirstein AS. Sarcoidosis and transplantation. Sarcoidosis Vasc Diffuse Lung Dis. 1997;14:16-22. (Pubitemid 27170551)